KSI-301是基于ABC平台开发的一款抗VEGF药物,旨在延长药物在眼部组织的作用时间,从而改善视网膜血管疾病患者的预后,并为糖尿病眼病患者提供早期治疗和预防视力丧失的方案。尽管KSI-301显示出了治疗潜力,但Kodiak还是决定终...查看全文
SeekingBiotech2023-07-24 21:52
$Kodiak Sciences(KOD)$
KOD Announces Topline Results from its Phase 3 Studies of Tarcocimab Tedromer in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema.
GLEAM and GLIMMER studies did not meet their primary efficacy endpoints. 又一个错失终点nAM...查看全文
不入流资讯2023-07-24 19:50
$Kodiak Sciences(KOD)$ Kodiak Sciences plummets 47% after scraping development of eye disorder drug查看全文
产业链观察2023-07-24 18:08
#药闻简讯# $Kodiak Sciences(KOD)$ 公布 Tarcocimab Tedromer 治疗新生血管性老年黄斑变性和糖尿病性黄斑水肿的 3 期研究的初步结果。
GLEAM和GLIMMER研究未达到主要疗效终点#临床研究失败#查看全文
产业链观察2022-08-08 19:55
药闻▶2022年8月8日,$Kodiak Sciences(KOD)$ 宣布,其新型抗体生物聚合物结合物Tarcocimab tedromer(KSI-301;tarcocimab)的BEACON 3期研究达到了主要终点,即与阿夫利贝特相比,视网膜静脉闭塞导致的黄斑水肿患者在第24周的视力变化不低于基线。Tarcocimab还显示出强大的解剖学反...查看全文
牛唐2022-06-02 11:21
医药板块速评(2022.06.01)
本期内容提示:
1、9月暂停加息预期打破,大盘后续走势如何看?
2、多家公司市值低于现金,哪些烟蒂股有反转机会?
3、$Kodiak Sciences(KOD)$ 积极股东介入,是否有反转机会?
$特斯拉(TSLA)$ $哔哩哔哩(BILI)$查看全文
牛唐2022-02-24 22:45
医药板块速评(2022.02.23)
本期内容提示:
1、大盘暴跌,如何搭建做空工具组合?
2、大跌之下,哪些医药股有抄底机会?
3、$Kodiak Sciences(KOD)$ 暴跌,知名机构重仓,是否有抄底机会?
$百济神州-U(SH688235)$ $药明康德(SH603259)$查看全文
PracticeOnly2022-02-24 10:27
$Kodiak Sciences(KOD)$ ,其实只说明了一点,生物医药不确定性太大了,不是每个人都能承受得起动辄20%甚至50%以上的跌幅。如果真想好了从中淘金,最好分散点。当然,异常自信的除外。不要自信心爆棚,但投资结果又很糟糕,那就不是“自信”是“自负”了。查看全文
$Kodiak Sciences(KOD)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-23-010314 Act: 34 Size: 13 MB 网页链接
$Kodiak Sciences(KOD)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-23-010303 Act: 34 Size: 367 KB 网页链接
$Kodiak Sciences(KOD)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-23-039194 Act: 34 Size: 43 KB 网页链接
$Kodiak Sciences(KOD)$ 5 Annual statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-009128 Size: 4 KB 网页链接
$Kodiak Sciences(KOD)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000080255-23-002691 Act: 34 Size: 7 KB 网页链接
$Kodiak Sciences(KOD)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-23-016308 Act: 34 Size: 13 KB 网页链接
$Kodiak Sciences(KOD)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001306550-23-007727 Act: 34 Size: 13 KB 网页链接
$Kodiak Sciences(KOD)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-22-023870 Act: 34 Size: 6 MB 网页链接
$Kodiak Sciences(KOD)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-22-023842 Act: 34 Size: 353 KB 网页链接
$Kodiak Sciences(KOD)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-22-016151 Act: 34 Size: 6 MB 网页链接